Zidovudine is beneficial in human immunodeficiency virus associated nephropathy

American Journal of Nephrology

Volumn 15, Issue 3, 1995, Pages 217-221

  Ifudu, Onyekachi ^a   Sreepada Rao, T K ^a   Tan, Caridad C ^a   Fleisch Man, Heidi ^a   Chirgwin, Keith ^a   Friedman, Eli A ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

End stage renal disease; Human immunodeficiency virus; Nephropathy; Proteinuria; Zidovudine

Indexed keywords

CD4 ANTIGEN; CREATININE; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE DURATION; DRUG EFFICACY; FEMALE; GLOMERULOSCLEROSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY HYPERTROPHY; LEUKOPENIA; MALE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEINURIA; UREMIA;

ADULT; AIDS-ASSOCIATED NEPHROPATHY; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; PROSPECTIVE STUDIES; ZIDOVUDINE;

EID: 0028998884     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000168835     Document Type: Article

References (23)

1. Rao TKS, Filippone FJ, Nicastri AD, Landesman SH, Frank E, Chen CK, Friedman EA: Associated local and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med 1984;310:669-673.
2. Humphreys MH, Schoenfeld PY: Renal complications in patients with the acquired immunodeficiency syndrome (AIDS). Am J Nephrol 1987;7:1.
3. Rao TKS, Friedman EA, Nicastri AD: The types of renal disease in the acquired immunodeficiency syndrome. N Engl J Med 1987;316:1062-1068.
4. Bourgoignie JJ: Renal complications of human immunodeficiency virus type 1. Kidney Int 1990;37:1571-1584.
5. Langs C, Gallo GR, Schacht RG, Sidhu G, Baldwin DS: Rapid renal failure in AIDS-associated focal glomerulosclerosis. Arch Intern Med 1990;150:287-292.
6. Carbone L, D’Agati V, Cheng JT, Appel GB: The course and prognosis of human immunodeficiency virus-associated nephropathy. Am J Med 1989;87:389-395.
7. Fischl MA, Richman DD, Greieco MIL, Gottlieb MS, Volberding PA, Laskin OL, Leedom JM, Groopman JE, Mildvan D, Schooley RT, Jackson GG, Durack DT, King D, and The AZT Collaborative Working Group: The efficacy of azidothymidine in the treatment of patients with AIDS and AIDS-related complex. N Engl J Med 1987;317:185-191.
8. Cooper DA, Gatell JM, Kroon S, Clumeck N, Millard J, Goebel FD, Bruun JN, Stingl G, Melville RE, Gonzalez-Lahoz J, Stevens JW, Fiddian AP and The European-Australian Collaborative Group: Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. N Engl J Med 1993;329:297-303.
9. Cook PP, Appel RG: Prolonged clinical improvement in HIV-associated nephropathy with zidovudine therapy. J Am Soc Nephrol 1990;1:842.
10. Lam M, Park MC: HIV-associated nephropathy: Beneficial effect of zidovudine therapy. N Engl J Med 1990;323:1775-1776.
11. Babul-Gay ML, Echard M, Kleinknecht D, Meyrier A: Zidovudine and nephropathy with human immunodeficiency virus (HIV) infection. Ann Intern Med 1989;111:856-857.
12. Harrer T, Hunzelmann N, Stoll R, Baur A, Kalden JR: Therapy for HIV-1-related nephritis with zidovudine. AIDS 1990;4:815-824.
13. Michel C, Dosquet P, Ronco P, Mougenot B, Viron B, Mignon F: Nephropathy associated with infection by human immunodeficiency vims: A report on 11 cases including 6 treated with zidovudine. Nephron 1992;62:434-440.
14. Rao TK, Mallis LR, Friedman EA: Nephropathy as the initial manifestation of human immunodeficiency virus disease (abstract). Kidney Int 1988;33:205.
15. Rao TK, Manis T, Friedman EA: Dismal prognosis despite maintenance hemodialysis in AIDS nephropathy and chronic uremia. AS-AIO Trans 1985;31:160-163.
16. Tolkoff-Rubin NE, Rubin RH: Uremia and host defenses. N Engl J Med 1990;322:770-772.
17. Cohen AH, Sun NCJ, Shapshak P, Imagawa D: Demonstration of human immunodeficiency virus in renal epithelium in HIV-associated nephropathy. Mod Pathol 1989;21:125-128.
18. Barbiano Di Belgiojoso G, Genderini A, Vago L, Parravicini C, Bertoli S, Landriani N: Absence of HIV antigens in renal tissue from patients with HIV-associated nephropathy. Nephrol Dial Transplant 1990;5:489-492.
19. Nelson JA, Wiley CA, Reynolds-Kohler C, Reese CE. Margenetten W. Levy JA: Human immunodeficiency vims detected in bowel epithelium from patients with gastrointestinal symptoms. Lancet 1988;i:259.
20. Kintmel PL, Ferreira-Centeno A, Farkas-Szallasi T, Abraham AA, Garrett CT: Viral DNA in microdissected renal biopsy tissue from HIVinfected patients with nephrotic syndrome. Kidney Int 1993;43:1347-1352.
21. Mitsuya H, Weinhold KJ, Furman PA, St Clair MH, Wusinoff-Lehrman SN, Gallo RC, Bolognesi D, Barry DW, Broder S: 3’-Azido-3’-deoxythymidine (BW A509U): An antiviral agent that inhibits the inlectivity and cytopathic effect of human T-lymphotropic vims type III/ lymphadenopathy-associated vims in vitro. Proc Natl Acad Sci USA 1985;82:7096-7100.
22. Furman PA, St Clair M, Weinhold K, Fyfe JA, Lehrman SN, Barry DW: Selective inhibition of HTLV-III by BW A509U (abstract). 25th Intersci Conf on Antimicrobial Agents and Chemotherapy, Minneapolis. 1985.
23. De Alvaro F, Lundin AP, Chirgwin K, Zhao ZH, Friedman EA: Proteinuria in HIV-infected patients (abstract). J Am Soc Nephrol 1991;1:306.